Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal
Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.
presented by
Hill-Rom to acquire healthcare communications company Voalte for up to $195M
The acquisition price was $180 million in upfront cash with a potential $15 million additional payment, dependent on meeting certain commercial milestones.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
EarlySense secures $39M for patient monitoring solutions
The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.
Hill-Rom sells WatchChild fetal monitor to AI company PeriGen
The sale, announced Tuesday, will allow PeriGen to apply its clinical decision support and artificial intelligence to the WatchChild obstetrics device and offer an integrated product. It also allows Hill-Rom to shed a product that doesn't quite fit its core mission.
In deal with Qualcomm Life, Hill-Rom connects vest to IoT to help track cystic fibrosis patient data
The vest gathers patients’ airway clearance therapy session information, such as how many minutes the session lasted, duration of cough pauses, frequency settings and transmits it to the portal where physicians can see the data.